Caleb Bliss

1.6k total citations
32 papers, 893 citations indexed

About

Caleb Bliss is a scholar working on Epidemiology, Genetics and Infectious Diseases. According to data from OpenAlex, Caleb Bliss has authored 32 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 6 papers in Genetics and 5 papers in Infectious Diseases. Recurrent topics in Caleb Bliss's work include Inflammatory Bowel Disease (6 papers), Attention Deficit Hyperactivity Disorder (4 papers) and Substance Abuse Treatment and Outcomes (4 papers). Caleb Bliss is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Attention Deficit Hyperactivity Disorder (4 papers) and Substance Abuse Treatment and Outcomes (4 papers). Caleb Bliss collaborates with scholars based in United States, Australia and Italy. Caleb Bliss's co-authors include Timothy Heeren, Edward Bernstein, Judith Bernstein, David Dorfman, Erika M. Edwards, Michael Winter, Damaris J. Rohsenow, Jonathan Howland, Carmel Fitzgerald and Harold L. Lazar and has published in prestigious journals such as Gastroenterology, Annals of Surgery and American Journal of Public Health.

In The Last Decade

Caleb Bliss

32 papers receiving 862 citations

Peers

Countries citing papers authored by Caleb Bliss

Since Specialization

Citations

This map shows the geographic impact of Caleb Bliss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caleb Bliss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caleb Bliss more than expected).

Fields of papers citing papers by Caleb Bliss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caleb Bliss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caleb Bliss. The network helps show where Caleb Bliss may publish in the future.

Co-authorship network of co-authors of Caleb Bliss

This figure shows the co-authorship network connecting the top 25 collaborators of Caleb Bliss. A scholar is included among the top collaborators of Caleb Bliss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caleb Bliss. Caleb Bliss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 Oaks Trial 2025 ·American Journal of Ophthalmology ·Usha Chakravarthy, Roy Schwartz, Robyn H. Guymer, Frank G. Holz, Aleksandra Rachitskaya, Stela Vujosevic, (unknown), (unknown), A. Yasin Alibhai, Eric M. Moult, (unknown), Caleb Bliss, Caroline R. Baumal, Nadia K. Waheed	3
2	Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease 2023 ·Journal of Crohn s and Colitis ·Séverine Vermeire, Silvio Danese, William J. Sandborn, Stefan Schreiber, Stephen B. Hanauer, Geert D’Haens, Péter Nagy, Manoj Kumar Thakur, Caleb Bliss, (unknown), Martina Goetsch, Kenneth J. Gorelick, Walter Reinisch	8
3	Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses 2020 ·European Child & Adolescent Psychiatry ·David Coghill, (unknown), (unknown), Caleb Bliss, Brigitte Robertson, Michael Huß	8
4	DOP51 Biomarker and pharmacokinetic data from the TURANDOT II open-label extension study of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody SHP647 in patients with ulcerative colitis 2019 ·Journal of Crohn s and Colitis ·Walter Reinisch, William J. Sandborn, Silvio Danese, Xavier Hébuterne, Maria Kłopocka, Dino Tarabar, Tomáš Vaňásek, (unknown), Paul Hellstern, (unknown), Miles Sparrow, (unknown), Martina Goetsch, Caleb Bliss, (unknown), Fabio Cataldi, Séverine Vermeire	2
5	Clinical Characteristics and Treatment Response to Lisdexamfetamine Dimesylate Versus Placebo in Adults With Binge Eating Disorder 2019 ·The Journal of Clinical Psychiatry ·Susan G. Kornstein, Caleb Bliss, Judith C. Kando, Manisha Madhoo	9
6	Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies 2018 ·Neuropsychiatric Disease and Treatment ·Leslie Citrome, Judith C. Kando, Caleb Bliss	6
7	A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis 2018 ·BMC Pharmacology and Toxicology ·Melissa Palmer, L. J. JENNINGS, Debra G. Silberg, Caleb Bliss, Patrick Martin	26
8	Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate 2018 ·CNS Drugs ·David Coghill, Tobias Banaschewski, Caleb Bliss, Brigitte Robertson, Alessandro Zuddas	13
9	Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD 2017 ·Journal of Attention Disorders ·David Coghill, Alain Joseph, Vanja Sikirica, Mark Kosinski, Caleb Bliss, Michael Huß	18
10	Absorption, Distribution, Metabolism, and Excretion of [14C]-Volixibat in Healthy Men: Phase 1 Open-Label Study 2017 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), Melissa Palmer, Debra G. Silberg, L. J. JENNINGS, Caleb Bliss, Paul T. Martin	12
11	Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae : a pooled analysis of Phase 3 clinical trials 2016 ·Journal of Antimicrobial Chemotherapy ·Myra W. Popejoy, David L. Paterson, Daniel Cloutier, Jennifer A. Huntington, Benjamin Miller, Caleb Bliss, Judith N. Steenbergen, Ellie Hershberger, Obiamiwe Umeh, Keith S. Kaye	95
12	The Impact of a Brief Motivational Intervention on Unprotected Sex and Sex While High Among Drug-Positive Emergency Department Patients Who Receive STI/HIV VC/T and Drug Treatment Referral as Standard of Care 2012 ·AIDS and Behavior ·Edward Bernstein, (unknown), Timothy Heeren, Michael Winter, Caleb Bliss, Guillermo Madico, Judith Bernstein	22
13	Long‐term Follow‐up After Voluntary Human Immunodeficiency Virus/Sexually Transmitted Infection Counseling, Point‐of‐service Testing, and Referral to Substance Abuse Treatment From the Emergency Department 2012 ·Academic Emergency Medicine ·Edward Bernstein, Timothy Heeren, Michael Winter, (unknown), Caleb Bliss, Guillermo Madico, (unknown), Judith Bernstein	13
14	Incidence and Predictors of Acute Kidney Injury in an Urban Cohort of Subjects with HIV and Hepatitis C Virus Coinfection 2011 ·AIDS Patient Care and STDs ·Shikha Garg, Melanie P. Hoenig, Erika M. Edwards, Caleb Bliss, Timothy Heeren, Sheila Tumilty, Alexander Y. Walley, Margaret James Koziel, Paul R. Skolnik, C. Robert Horsburgh, Deborah Cotton	18
15	Effects of Aggressive Versus Moderate Glycemic Control on Clinical Outcomes in Diabetic Coronary Artery Bypass Graft Patients 2011 ·Annals of Surgery ·Harold L. Lazar, (unknown), Stuart R. Chipkin, Carmel Fitzgerald, Caleb Bliss, Howard Cabral	104
16	Hangover sensitivity after controlled alcohol administration as predictor of post-college drinking. 2011 ·Journal of Abnormal Psychology ·Damaris J. Rohsenow, Jonathan Howland, Michael Winter, Caleb Bliss, (unknown), Timothy Heeren, (unknown)	28
17	A Brief Motivational Interview in a Pediatric Emergency Department, Plus 10‐day Telephone Follow‐up, Increases Attempts to Quit Drinking Among Youth and Young Adults Who Screen Positive for Problematic Drinking 2010 ·Academic Emergency Medicine ·Judith Bernstein, Timothy Heeren, (unknown), David Dorfman, Caleb Bliss, Michael Winter, Edward Bernstein	99
18	Hangover Predicts Residual Alcohol Effects on Psychomotor Vigilance the Morning After Intoxication 2010 ·Journal of Addiction Research & Therapy ·Jonathan Howland, Damaris J. Rohsenow, Caleb Bliss, Alissa Almeida, (unknown)	12
19	The acute effects of caffeinated versus non‐caffeinated alcoholic beverage on driving performance and attention/reaction time 2010 ·Addiction ·Jonathan Howland, Damaris J. Rohsenow, J. Todd Arnedt, Caleb Bliss, Sarah K. Hunt, (unknown), Timothy Heeren, Michael Winter, (unknown), Daniel J. Gottlieb	65
20	The effects of binge drinking on college students' next‐day academic test‐taking performance and mood state 2010 ·Addiction ·Jonathan Howland, Damaris J. Rohsenow, Jacey Greece, (unknown), Alissa Almeida, Timothy Heeren, Michael Winter, Caleb Bliss, Sarah K. Hunt, John A. Hermos	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact